338840 — Y Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Y Biologics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16,948	12,983	20,898	12,204	44,269
Net Total Accounts Receivable
Net Total Receivables	2,083	895	639	194	352
Prepaid Expenses
Total Other Current Assets
Total Current Assets	19,845	18,034	21,763	12,471	44,815
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16,824	10,801	8,009	7,407	6,899
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	38,245	29,323	30,294	21,727	55,798
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6,209	16,195	5,508	2,444	1,239
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9,803	17,029	6,886	3,371	29,200
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	28,441	12,293	23,408	18,356	26,597
Total Liabilities & Shareholders' Equity	38,245	29,323	30,294	21,727	55,798
Total Common Shares Outstanding
Total Preferred Shares Outstanding